BIOMARKER:

BARD1 mutation

Entrez ID:

BARD1 mutation BARD1 mutation	Prostate Cancer Prostate Cancer	BARD1 mutation BARD1 mutation	Prostate Cancer Prostate Cancer	olaparib Sensitive: A2 - Guideline	olaparib Sensitive: A2 - Guideline
BARD1 mutation BARD1 mutation	Ovarian Cancer Ovarian Cancer	BARD1 mutation BARD1 mutation	Ovarian Cancer Ovarian Cancer	olaparib Sensitive: B - Late Trials	olaparib Sensitive: B - Late Trials
BARD1 mutation BARD1 mutation	HER2 Negative Breast Cancer HER2 Negative Breast Cancer	BARD1 mutation BARD1 mutation	HER2 Negative Breast Cancer HER2 Negative Breast Cancer	durvalumab Sensitive: C2 – Inclusion Criteria	durvalumab Sensitive: C2 – Inclusion Criteria

Associations